Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length
Source abstract
Abstract
Poly(ethylene glycol) (PEG) has been extensively used to coat the surface of nanocarriers to improve their physicochemical properties and allow the grafting of targeting moieties. Still, to date there is no common agreement on the ideal PEG coverage-density or length to be used for optimum vector performance. In this study, we aimed to investigate the impact of both PEG density and length on the vectoring capacity of neuron-targeted gene-carrying trimethyl chitosan nanoparticles. The non-toxic fragment from the tetanus toxin (HC) was coupled to a 5 kDa heterobifunctional PEG (HC-PEG5k) reactive for the thiol groups inserted into the polymer backbone and grafted at different densities onto the nanoparticles. Internalization and transfection studies on neuronal versus non-neuronal cell lines allowed to determine the PEG density of 2 mol% of PEG chains per mol of primary amine groups as the one with superior biological performance. To enhance HC exposure and maximize cell-nanoparticle specific interaction, NPs containing different ratios of HC-PEG5k and 2 kDa methoxy-PEG at the same grafting density were produced. By intercalating HC-PEG5k with methoxy-PEG2k we attained the best performance in terms of internalization (higher payload delivery into cells) and transfection efficiency, using twice lower amount of HC. This outcome highlights the need for fine-tuning of PEG-modified nanoparticles towards the achievement of optimal targeting. Statement of significance The amount and exposure of targeting moieties at a nanoparticle surface are critical parameters regarding the targeting potential of nanosized delivery vectors. However, to date, few studies have considered fundamental aspects impacting the ligand-receptor pair interaction, such as the effect of spacer chain length, flexibility or conformation. By optimizing the PEG spacer density and chain length grafted into nanoparticles, we were able to establish the formulation that maximizes cell-nanoparticle specific interaction and has superior biological performance. Our work shows that the precise adjustment of the PEG coverage-density presents a significant impact on the selectivity and bioactivity of the developed formulation, emphasizing the need for the fine-tuning of PEG-modified nanoparticles for the successful development of the next-generation nanomedicines.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Graphene and Nanomaterials Applications · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. A holistic approach to targeting disease with polymeric nanoparticles10.1038/nrd4503 ↗
2. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging10.1016/j.nano.2011.05.016 ↗
3. Advanced targeted nanomedicine10.1016/j.jbiotec.2015.01.009 ↗
4. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation10.1039/c2cs15344k ↗
5. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
6. Active targeting schemes for nanoparticle systems in cancer therapeutics10.1016/j.addr.2008.08.005 ↗
7. Nanoparticle PEGylation for imaging and therapy10.2217/nnm.11.19 ↗
8. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles10.1078/0171-9335-00363 ↗
9. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma10.1016/j.addr.2010.09.001 ↗
10. Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry10.1016/j.jconrel.2015.03.011 ↗
11. Translating chitosan to clinical delivery of nucleic acid-based drugs10.1557/mrs.2013.314 ↗
12. A high-throughput bioimaging study to assess the impact of chitosan-based nanoparticle degradation on DNA delivery performance10.1016/j.actbio.2016.09.037 ↗
13. Atomic force microscopy as a tool to assess the specificity of targeted nanoparticles in biological models of high complexity10.1002/adhm.201700597 ↗
14. Microfluidic-based platform to mimic the in vivo peripheral administration of neurotropic nanoparticles10.2217/nnm-2016-0247 ↗
15. BDNF gene delivery mediated by neuron-targeted nanoparticles is neuroprotective in peripheral nerve injury10.1016/j.biomaterials.2016.12.025 ↗
16. Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: beyond a paradigm10.1016/j.ejps.2017.09.048 ↗
17. Enhanced target recognition of nanoparticles by cocktail PEGylation with chains of varying lengths10.1039/C5CC06661A ↗
18. USA Food and Drug Administration · 2012
19. Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c10.1016/j.jconrel.2010.01.018 ↗
20. Analysis of mutants of tetanus toxin HC fragment: ganglioside binding, cell binding and retrograde axonal transport properties10.1046/j.1365-2958.2000.02091.x ↗
21. Chitosan-based gene delivery vectors targeted to the peripheral nervous system10.1002/jbm.a.32874 ↗
22. Extended depth of field imaging for high speed cell analysis10.1002/cyto.a.20370 ↗
23. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity10.1046/j.1432-1327.2000.01606.x ↗
24. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery10.1016/j.ijpharm.2009.07.028 ↗
25. Integrated analysis of biological samples by imaging flow cytometry10.1017/S1431927615014282 ↗
26. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation10.1016/j.jconrel.2014.04.017 ↗
27. Understanding biophysicochemical interactions at the nano-bio interface10.1038/nmat2442 ↗
28. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface10.1038/nnano.2012.237 ↗
29. Protein corona significantly reduces active targeting yield10.1039/c3cc37307j ↗
30. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake10.1016/S0142-9612(01)00030-8 ↗
31. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers10.1016/j.biomaterials.2005.03.036 ↗
32. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-κB decoy in mice10.1023/A:1016152831963 ↗
33. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system10.1021/bc025529v ↗
34. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity10.1016/S0168-3659(02)00002-0 ↗
35. Fine-tuned PEGylation of chitosan to maintain optimal siRNA-nanoplex bioactivity10.1016/j.carbpol.2016.01.010 ↗
36. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells10.1039/c3nr05559k ↗
37. Conformations of polymers attached to an interface10.1021/ma60077a009 ↗
38. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)10.1023/A:1020186505848 ↗
39. Design and development of polymers for gene delivery10.1038/nrd1775 ↗
40. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes10.1074/jbc.M308643200 ↗
41. Chitosan-based siRNA delivery systems10.1016/j.jconrel.2013.08.005 ↗
42. Smart polymeric nanocarriers for small nucleic acid delivery10.5582/ddt.2016.01061 ↗